{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T02:22:46Z","timestamp":1783045366795,"version":"3.54.6"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T00:00:00Z","timestamp":1503360000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["Marie Sklodowska-Curie grant agreement"],"award-info":[{"award-number":["Marie Sklodowska-Curie grant agreement"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA124675"],"award-info":[{"award-number":["CA124675"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA184228"],"award-info":[{"award-number":["CA184228"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["CA183031"],"award-info":[{"award-number":["CA183031"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Prostate Cancer Foundation Young Investigator Award"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Nucl Med"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s12149-017-1201-4","type":"journal-article","created":{"date-parts":[[2017,8,22]],"date-time":"2017-08-22T08:46:52Z","timestamp":1503391612000},"page":"696-702","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Patterns of uptake of prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL in peripheral ganglia"],"prefix":"10.1007","volume":"31","author":[{"given":"Rudolf A.","family":"Werner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Sheikhbahaei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystyna M.","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehrbod S.","family":"Javadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilja B.","family":"Solnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley E.","family":"Ross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamad E.","family":"Allaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth J.","family":"Pienta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Lapa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas K.","family":"Buck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Higuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin G.","family":"Pomper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Gorin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven P.","family":"Rowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,8,22]]},"reference":[{"issue":"3","key":"1201_CR1","first-page":"241","volume":"59","author":"AP Kiess","year":"2015","unstructured":"Kiess AP, Banerjee SR, Mease RC, Rowe SP, Rao A, Foss CA, et al. Prostate-specific membrane antigen as a target for cancer imaging and therapy. Q J Nucl Med Mol Imaging. 2015;59(3):241\u201368.","journal-title":"Q J Nucl Med Mol Imaging"},{"issue":"4","key":"1201_CR2","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nrurol.2016.26","volume":"13","author":"T Maurer","year":"2016","unstructured":"Maurer T, Eiber M, Schwaiger M, Gschwend JE. Current use of PSMA-PET in prostate cancer management. Nat Rev Urol. 2016;13(4):226\u201335.","journal-title":"Nat Rev Urol"},{"issue":"4","key":"1201_CR3","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11307-015-0850-8","volume":"17","author":"Z Szabo","year":"2015","unstructured":"Szabo Z, Mena E, Rowe SP, Plyku D, Nidal R, Eisenberger MA, et al. Initial evaluation of [(18)F]DCFPyL for prostate-specific membrane antigen (PSMA)-targeted PET imaging of prostate cancer. Mol Imaging Biol. 2015;17(4):565\u201374.","journal-title":"Mol Imaging Biol"},{"issue":"10","key":"1201_CR4","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s12149-015-1017-z","volume":"29","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Gorin MA, Hammers HJ, Som Javadi M, Hawasli H, Szabo Z, et al. Imaging of metastatic clear cell renal cell carcinoma with PSMA-targeted (1)(8)F-DCFPyL PET\/CT. Ann Nucl Med. 2015;29(10):877\u201382.","journal-title":"Ann Nucl Med"},{"issue":"4","key":"1201_CR5","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1007\/s11307-015-0866-0","volume":"17","author":"M Dietlein","year":"2015","unstructured":"Dietlein M, Kobe C, Kuhnert G, Stockter S, Fischer T, Schomacker K, et al. Comparison of [(18)F]DCFPyL and [(68)Ga]Ga-PSMA-HBED-CC for PSMA-PET imaging in patients with relapsed prostate cancer. Mol Imaging Biol. 2015;17(4):575\u201384.","journal-title":"Mol Imaging Biol"},{"issue":"6","key":"1201_CR6","doi-asserted-by":"publisher","first-page":"942","DOI":"10.2967\/jnumed.116.179739","volume":"58","author":"X Li","year":"2017","unstructured":"Li X, Rowe SP, Leal JP, Gorin MA, Allaf ME, Ross AE, et al. Semiquantitative parameters in PSMA-targeted PET imaging with 18F-DCFPyL: variability in normal-organ uptake. J Nucl Med. 2017;58(6):942\u20136.","journal-title":"J Nucl Med"},{"issue":"4","key":"1201_CR7","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1111\/1754-9485.12357","volume":"60","author":"WP Law","year":"2016","unstructured":"Law WP, Fiumara F, Fong W, Miles KA. Gallium-68 PSMA uptake in adrenal adenoma. J Med Imaging Radiat Oncol. 2016;60(4):514\u20137.","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"4","key":"1201_CR8","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1097\/RLU.0000000000001084","volume":"41","author":"GL Kanthan","year":"2016","unstructured":"Kanthan GL, Drummond J, Schembri GP, Izard MA, Hsiao E. Follicular thyroid adenoma showing avid uptake on 68\u00a0Ga PSMA-HBED-CC PET\/CT. Clin Nucl Med. 2016;41(4):331\u20132.","journal-title":"Clin Nucl Med"},{"issue":"2","key":"1201_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.18383\/j.tom.2015.00169","volume":"1","author":"SP Rowe","year":"2015","unstructured":"Rowe SP, Deville C, Paller C, Cho SY, Fishman EK, Pomper MG, et al. Uptake of 18F-DCFPyL in Paget\u2019s disease of bone, an important potential pitfall in clinical interpretation of PSMA PET studies. Tomography. 2015;1(2):81\u20134.","journal-title":"Tomography"},{"issue":"6","key":"1201_CR10","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2174\/092986712799034888","volume":"19","author":"C Barinka","year":"2012","unstructured":"Barinka C, Rojas C, Slusher B, Pomper M. Glutamate carboxypeptidase II in diagnosis and treatment of neurologic disorders and prostate cancer. Curr Med Chem. 2012;19(6):856\u201370.","journal-title":"Curr Med Chem"},{"issue":"6","key":"1201_CR11","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/sj.emboj.7600969","volume":"25","author":"JR Mesters","year":"2006","unstructured":"Mesters JR, Barinka C, Li W, Tsukamoto T, Majer P, Slusher BS, et al. Structure of glutamate carboxypeptidase II, a drug target in neuronal damage and prostate cancer. EMBO J. 2006;25(6):1375\u201384.","journal-title":"EMBO J"},{"issue":"2","key":"1201_CR12","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1007\/s00259-014-2915-3","volume":"42","author":"T Krohn","year":"2015","unstructured":"Krohn T, Verburg FA, Pufe T, Neuhuber W, Vogg A, Heinzel A, et al. [(68)Ga]PSMA-HBED uptake mimicking lymph node metastasis in coeliac ganglia: an important pitfall in clinical practice. Eur J Nucl Med Mol Imaging. 2015;42(2):210\u20134.","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"11","key":"1201_CR13","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1002\/jlcr.3430","volume":"59","author":"HT Ravert","year":"2016","unstructured":"Ravert HT, Holt DP, Chen Y, Mease RC, Fan H, Pomper MG, et al. An improved synthesis of the radiolabeled prostate-specific membrane antigen inhibitor, [(18)F]DCFPyL. J Label Compd Radiopharm. 2016;59(11):439\u201350.","journal-title":"J Label Compd Radiopharm"},{"issue":"3","key":"1201_CR14","doi-asserted-by":"publisher","first-page":"655","DOI":"10.2214\/ajr.158.3.1739014","volume":"158","author":"QH Hogan","year":"1992","unstructured":"Hogan QH, Erickson SJ. MR imaging of the stellate ganglion: normal appearance. AJR Am J Roentgenol. 1992;158(3):655\u20139.","journal-title":"AJR Am J Roentgenol"},{"key":"1201_CR15","doi-asserted-by":"publisher","DOI":"10.1111\/1754-9485.12622","author":"GL Kanthan","year":"2017","unstructured":"Kanthan GL, Hsiao E, Vu D, Schembri GP. Uptake in sympathetic ganglia on 68\u00a0Ga-PSMA-HBED PET\/CT: a potential pitfall in scan interpretation. J Med Imaging Radiat Oncol. 2017. doi: 10.1111\/1754-9485.12622 .","journal-title":"J Med Imaging Radiat Oncol"},{"issue":"5","key":"1201_CR16","doi-asserted-by":"publisher","first-page":"687","DOI":"10.2967\/jnumed.117.190157","volume":"58","author":"C Kesch","year":"2017","unstructured":"Kesch C, Kratochwil C, Mier W, Kopka K, Giesel FL. 68\u00a0Ga or 18F for prostate cancer imaging? J Nucl Med. 2017;58(5):687\u20138.","journal-title":"J Nucl Med"},{"issue":"7","key":"1201_CR17","doi-asserted-by":"publisher","first-page":"779","DOI":"10.3390\/ph7070779","volume":"7","author":"M Eder","year":"2014","unstructured":"Eder M, Neels O, Muller M, Bauder-Wust U, Remde Y, Schafer M, et al. Novel preclinical and radiopharmaceutical aspects of [68\u00a0Ga]Ga-PSMA-HBED-CC: a new PET tracer for imaging of prostate cancer. Pharmaceuticals (Basel). 2014;7(7):779\u201396.","journal-title":"Pharmaceuticals (Basel)."},{"issue":"8","key":"1201_CR18","doi-asserted-by":"publisher","first-page":"e0136583","DOI":"10.1371\/journal.pone.0136583","volume":"10","author":"N Steiber","year":"2015","unstructured":"Steiber N. Population aging at cross-roads: diverging secular trends in average cognitive functioning and physical health in the older population of Germany. PLoS One. 2015;10(8):e0136583.","journal-title":"PLoS One"},{"issue":"2","key":"1201_CR19","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1002\/cphy.c110025","volume":"2","author":"FW Booth","year":"2012","unstructured":"Booth FW, Roberts CK, Laye MJ. Lack of exercise is a major cause of chronic diseases. Compr Physiol. 2012;2(2):1143\u2013211.","journal-title":"Compr Physiol"},{"issue":"10","key":"1201_CR20","first-page":"2098","volume":"27","author":"J Shen","year":"2006","unstructured":"Shen J, Wang HY, Chen JY, Liang BL. Morphologic analysis of normal human lumbar dorsal root ganglion by 3D MR imaging. AJNR Am J Neuroradiol. 2006;27(10):2098\u2013103.","journal-title":"AJNR Am J Neuroradiol"},{"issue":"9","key":"1201_CR21","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1097\/00007632-199605010-00001","volume":"21","author":"T Hasegawa","year":"1996","unstructured":"Hasegawa T, Mikawa Y, Watanabe R, An HS. Morphometric analysis of the lumbosacral nerve roots and dorsal root ganglia by magnetic resonance imaging. Spine (Phila Pa 1976). 1996;21(9):1005\u20139.","journal-title":"Spine (Phila Pa 1976)"}],"container-title":["Annals of Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12149-017-1201-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12149-017-1201-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T15:56:12Z","timestamp":1659369372000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12149-017-1201-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,22]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["1201"],"URL":"https:\/\/doi.org\/10.1007\/s12149-017-1201-4","relation":{},"ISSN":["0914-7187","1864-6433"],"issn-type":[{"value":"0914-7187","type":"print"},{"value":"1864-6433","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,22]]},"assertion":[{"value":"4 August 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2017","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"MGP is a coinventor on a US Patent covering <sup>18<\/sup>F-DCFPyL, and as such is entitled to a portion of any licensing fees and royalties generated by this technology. This arrangement has been reviewed and approved by the Johns Hopkins University in accordance with its conflict-of-interest policies. MAG has served as a consultant to Progenics Pharmaceuticals, the licensee of <sup>18<\/sup>F-DCFPyL. MAG, KJP, MGP, and SPR have received research support from Progenics Pharmaceuticals.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"The Prostate Cancer Foundation Young Investigator Award, philanthropy raised by the James Buchanan Brady Urological Institute, and National Institutes of Health Grants CA134675 and CA183031. This project has received funding from the European Union\u2019s Horizon 2020 research and innovation programme under the Marie Sklodowska-Curie Grant agreement.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Sources of funding"}}]}}